Danske Bank A S Invests $51.53 Million in Agilent Technologies, Inc. $A

Danske Bank A S bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 401,467 shares of the medical research company’s stock, valued at approximately $51,528,000.

Several other large investors also recently made changes to their positions in the stock. Morningstar Investment Management LLC bought a new position in shares of Agilent Technologies in the 3rd quarter valued at about $2,118,000. CANADA LIFE ASSURANCE Co raised its stake in Agilent Technologies by 1.6% in the third quarter. CANADA LIFE ASSURANCE Co now owns 283,844 shares of the medical research company’s stock valued at $35,132,000 after buying an additional 4,545 shares during the period. Woodline Partners LP lifted its position in shares of Agilent Technologies by 971.8% in the third quarter. Woodline Partners LP now owns 330,535 shares of the medical research company’s stock valued at $42,424,000 after buying an additional 299,696 shares during the last quarter. Dark Forest Capital Management LP lifted its position in shares of Agilent Technologies by 19.1% in the third quarter. Dark Forest Capital Management LP now owns 15,126 shares of the medical research company’s stock valued at $1,941,000 after buying an additional 2,422 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI bought a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $2,015,000.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $111.41 on Thursday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $31.48 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 2.37 and a beta of 1.31. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27. The company has a 50-day simple moving average of $128.30 and a two-hundred day simple moving average of $135.59.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the prior year, the business posted $1.31 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on A shares. UBS Group decreased their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Citigroup raised their price target on Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Finally, The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.